Skip to main content
Figure 2 | BMC Medicine

Figure 2

From: Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety

Figure 2

The effect of 3 weeks treatment with prolonged release melatonin (PRM) and placebo on sleep latency in the low excretors and age 65-80 populations. Mean+standard error of mean values of the change from baseline in sleep latency from the sleep diary following 3 weeks of double blind treatment of low excretors (N = 86 per group) and age 65-80 years (N = 137 PRM, 144 placebo) populations with PRM and placebo. Asterisks denote significant difference between PRM and placebo groups (**P < 0.01).

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us